Impact of maternally derived meiotic aneuploidies on early embryonic development in vitro.


Journal

Journal of assisted reproduction and genetics
ISSN: 1573-7330
Titre abrégé: J Assist Reprod Genet
Pays: Netherlands
ID NLM: 9206495

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 07 07 2023
accepted: 21 08 2023
pmc-release: 01 11 2024
medline: 15 11 2023
pubmed: 27 8 2023
entrez: 26 8 2023
Statut: ppublish

Résumé

To assess early embryonic developmental potential of embryos affected by maternally inherited meiotic aneuploidies. This observational, descriptive study includes 930 oocytes from 151 patients which were retrospectively analyzed by combining the morphological assessment with the genetic results from polar body diagnosis. Of 930 oocytes examined, 566 (60.9%) were tested aneuploid. Developmental potential until cleavage stage was not affected by trisomies or monosomies (69.6% vs. 77.1%, p = 0.75). However, trisomies significantly more often resulted in top quality cleavage stage embryos compared to monosomies (20% vs. 17.6%, p =  < 0.01). Top quality blastocysts were more likely to be euploid than aneuploid (52.4% vs. 47.6%, p = 0.032). Additionally, significantly more aneuploid embryos resulted in developmental arrest compared to euploid embryos (15.3% vs. 6.7%, p = 0.003). Overall, there was no significant difference in the frequency of trisomies and monosomies in blastocyst stage embryos. (28.3% vs. 28.2%; p = 0.81). In contrast to earlier developmental stages, distribution of trisomies and monosomies did not differ in top quality blastocysts (8.3% vs. 5.3%, p = 0.32). However, certain chromosomal abnormalities showed a higher potential to develop into a top-rated blastocyst. These included monosomies 2, 5, 8, 10, 16, 17, 20, 21, and 22 and trisomies 2, 4, 5, 8, 9, 10, 11, 12, 13, 16, 17, 18 and 20. Meiotically induced maternal aneuploidies have different effects on early embryonic development. While no difference in developmental potential between monosomies and trisomies could be observed in blastocysts, cleavage stage quality was significantly affected by chromosomal aneuploidies.

Identifiants

pubmed: 37632639
doi: 10.1007/s10815-023-02922-9
pii: 10.1007/s10815-023-02922-9
pmc: PMC10643722
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2715-2723

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Inhorn MC, Patrizio P. Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century. Hum Reprod Update. 2015;21(4):411–26.
doi: 10.1093/humupd/dmv016 pubmed: 25801630
Gruhn JR, Zielinska AP, Shukla V, Blanshard R, Capalbo A, Cimadomo D, et al. Chromosome errors in human eggs shape natural fertility over reproductive life span. Science. 2019;365(6460):1466–9.
doi: 10.1126/science.aav7321 pubmed: 31604276 pmcid: 7212007
Hassold T, Hunt P. To err (meiotically) is human: the genesis of human aneuploidy. Nat Rev Genet. 2001;2(4):280–91.
doi: 10.1038/35066065 pubmed: 11283700
Lodge C, Herbert M. Oocyte aneuploidy—more tools to tackle an old problem. Proc Natl Acad Sci. 2020;117(22):11850–2.
doi: 10.1073/pnas.2005739117 pubmed: 32430318 pmcid: 7275742
Schenk M, Groselj-Strele A, Eberhard K, Feldmeier E, Kastelic D, Cerk S, et al. Impact of polar body biopsy on embryo morphokinetics-back to the roots in preimplantation genetic testing? J Assist Reprod Genet. 2018;35(8):1521–8.
doi: 10.1007/s10815-018-1207-4 pubmed: 29790071 pmcid: 6086803
Verpoest W, Staessen C, Bossuyt PM, Goossens V, Altarescu G, Bonduelle M, et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Hum Reprod. 2018;33(9):1767–76.
doi: 10.1093/humrep/dey262 pubmed: 30085138
Feichtinger M, Stopp T, Gobl C, Feichtinger E, Vaccari E, Madel U, et al. Increasing live birth rate by preimplantation genetic screening of pooled polar bodies using array comparative genomic hybridization. PLoS One. 2015;10(5):e0128317.
doi: 10.1371/journal.pone.0128317 pubmed: 26024488 pmcid: 4449032
Feichtinger M, Gobl C, Weghofer A, Feichtinger W. Reproductive outcome in European and Middle Eastern/North African patients. Reprod Biomed Online. 2016;33(6):684–9.
doi: 10.1016/j.rbmo.2016.09.003 pubmed: 27692599
ESHRE PGT Consortium and SIG-Embryology Biopsy Working Group, Kokkali G, Coticchio G, Bronet F, Celebi C, et al. ESHRE PGT Consortium and SIG Embryology good practice recommendations for polar body and embryo biopsy for PGT. Hum Reprod Open. 2020; 2020(3):hoaa020.
Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod. 2011;26(6):1270–83.
Reignier A, Lammers J, Barriere P, Freour T. Can time-lapse parameters predict embryo ploidy? A systematic review. Reprod Biomed Online. 2018;36(4):380–7.
doi: 10.1016/j.rbmo.2018.01.001 pubmed: 29398421
Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, Treff NR, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril. 2014;101(3):656-663 e1.
doi: 10.1016/j.fertnstert.2013.11.004 pubmed: 24355045
Lam A, Capuzzo M, Imbrogno MG, Donno V, Spedicato GA, Sacchi S, et al. The complex relationship between female age and embryo euploidy. Minerva Obstet Gynecol. 2021;73(1):103–10.
Coelho FF, Marques FK, Gonçalves MS, Almeida VC, Mateo EC, Ferreira AC. Detection of aneuploidies in spontaneous abortions by quantitative fluorescent PCR with short tandem repeat markers: a retrospective study. . Genet Mol Res. 2016;23(3):15.
Viotti M. Preimplantation Genetic Testing for Chromosomal Abnormalities: Aneuploidy, Mosaicism, and Structural Rearrangements. Genes (Basel). 2020;11(6):602.
Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW, et al. Down syndrome. Nat Rev Dis Primers. 2020;6(1):9.
doi: 10.1038/s41572-019-0143-7 pubmed: 32029743 pmcid: 8428796

Auteurs

Tschare L (T)

Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria.
Wunschbaby Institut Feichtinger, Vienna, Austria.

Ennemoser A (E)

Wunschbaby Institut Feichtinger, Vienna, Austria.

Carli L (C)

Wunschbaby Institut Feichtinger, Vienna, Austria.

Vaccari E (V)

Wunschbaby Institut Feichtinger, Vienna, Austria.

Feichtinger M (F)

Wunschbaby Institut Feichtinger, Vienna, Austria. Michael.Feichtinger@wunschbaby.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH